Search Results - "Boccieri, E."

Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID by Weaver, Kimberly N, Zhang, Xian, Dai, Xiangfeng, Watkins, Runa, Adler, Jeremy, Dubinsky, Marla C, Kastl, Arthur, Bousvaros, Athos, Strople, Jennifer A, Cross, Raymond K, Higgins, Peter D R, Ungaro, Ryan C, Bewtra, Meenakshi, Bellaguarda, Emanuelle, Farraye, Francis A, Boccieri, Margie E, Firestine, Ann, Kappelman, Michael D, Long, Millie D

“…Abstract Background Severe acute respiratory syndrome coronavirus 2 vaccination is recommended for all individuals with inflammatory bowel disease (IBD),…”
Get full text

Humoral immune response and safety of SARS‐CoV‐2 vaccination in very early onset inflammatory bowel disease by Kastl, Arthur J., Weaver, Kimberly N., Zhang, Xian, Strople, Jennifer A., Adler, Jeremy, Kelsen, Judith R., Dubinsky, Marla C., Bousvaros, Athos, Watkins, Runa, Dai, Colin, Cross, Raymond K., Higgins, Peter D. R., Ungaro, Ryan, Bewtra, Meenakshi, Bellaguarda, Emanuelle A., Farraye, Francis A., Chun, Kelly, Zikry, Michael, Bastidas, Monique, Boccieri, Margie E., Firestine, Ann, Long, Millie D., Kappelman, Michael D.

“…Children with very early onset inflammatory bowel disease (VEO‐IBD) may respond differently to coronavirus disease 2019 (COVID‐19) immunization compared to…”
Get full text

Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel Diseases by Kappelman, Michael D., Weaver, Kimberly N., Zhang, Xian, Dai, Xiangfeng, Watkins, Runa, Adler, Jeremy, Dubinsky, Marla C., Kastl, Arthur, Bousvaros, Athos, Strople, Jenifer A., Cross, Raymond K., Higgins, Peter D.R., Ungaro, Ryan C., Bewtra, Meenakshi, Bellaguarda, Emanuelle A., Farraye, Francis A., Boccieri, Margie E., Firestine, A., Chun, Kelly Y., Fernando, Manory, Bastidas, Monique, Zikry, Michael, Long, Millie D.

“…Although an additional coronavirus disease 2019 vaccine dose for immunocompromised persons has been recommended in some countries, further data to guide…”
Get full text

Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel Disease by Brenner, Erica J., Weaver, Kimberly N., Zhang, Xian, Kastl, Arthur J., Strople, Jennifer A., Adler, Jeremy, Dubinsky, Marla C., Bousvaros, Athos, Watkins, Runa, Dai, Xiangfeng, Chen, Wenli, Cross, Raymond K., Higgins, Peter D.R., Ungaro, Ryan C., Bewtra, Meenakshi, Bellaguarda, Emanuelle A., Farraye, Francis A., Chun, Kelly Y., Zikry, Michael, Bastidas, Monique, Firestine, Ann, Craig, Riley G., Boccieri, Margie E., Long, Millie D., Kappelman, Michael D.

“…COVID-19 vaccination prevents severe disease in most patients with inflammatory bowel disease (IBD), but immunosuppressive medications can blunt serologic…”
Get full text

Durable Immune Response and Long-term Efficacy of COVID-19 Vaccination in Children With Inflammatory Bowel Disease by Kastl, Arthur J, Brenner, Erica J, Weaver, Kimberly N, Zhang, Xian, Strople, Jennifer A, Adler, Jeremy, Dubinsky, Marla C, Bousvaros, Athos, Watkins, Runa, Dai, Xiangfeng, Chen, Wenli, Cross, Raymond K, Higgins, Peter D R, Ungaro, Ryan C, Bewtra, Meenakshi, Bellaguarda, Emanuelle A, Farraye, Francis A, Chun, Kelly Y, Zikry, Michael, Bastidas, Monique, Firestine, Ann M, Craig, Riley G, Boccieri, Margie E, Long, Millie D, Kappelman, Michael D

“…Children with inflammatory bowel disease (IBD) may have diminished serologic response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…”
Get full text

Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel Disease by Kastl, Arthur J., Weaver, Kimberly N., Zhang, Xian, Strople, Jennifer A., Adler, Jeremy, Dubinsky, Marla C., Bousvaros, Athos, Watkins, Runa, Dai, Xiangfeng, Chen, Wenli, Cross, Raymond K., Higgins, Peter D.R., Ungaro, Ryan C., Bewtra, Meenakshi, Bellaguarda, Emanuelle A., Farraye, Francis A., Chun, Kelly Y., Zikry, Michael, Fernando, Manory, Bastidas, Monique, Hernandez, Cristian G., Craig, Riley G., Boccieri, Margie E., Firestine, Anne, Long, Millie D., Kappelman, Michael D.

“…Children with inflammatory bowel disease (IBD) may respond differently to COVID-19 immunization as compared with healthy children or adults with IBD. Those…”
Get full text

Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease by Weaver, Kimberly N, Zhang, Xian, Dai, Xiangfeng, Chen, Wenli, Watkins, Runa, Adler, Jeremy, Dubinsky, Marla C, Kastl, Arthur, Bousvaros, Athos, Strople, Jennifer A, Cross, Raymond K, Higgins, Peter D R, Ungaro, Ryan C, Bewtra, Meenakshi, Bellaguarda, Emanuelle, Farraye, Francis A, Craig, Riley, Hernandez, Cristian, Boccieri, Margie E, Firestine, Ann, Chun, Kelly Y, Long, Millie D, Kappelman, Michael D

“…Lay Summary We demonstrate low rates of breakthrough coronavirus disease 2019 (COVID-19) infection and mild course of illness following severe acute…”
Get full text

Hematopoietic Stem/Progenitor Cells and Engineering: LONG-TERM DATA ON IMMUNE MONITORING OF CHILDREN GIVEN TCRαβ/CD19 CELL DEPLETED HLA-HAPLOIDENTICAL STEM TRANSPLANTATION (HAPLO-HSCT) by Bertaina, V., Sborgia, R., Marini, O., De Luca, C., Carta, R., Becilli, M., Pagliara, D., Quagliarella, F., Lucarelli, B., Boccieri, E., Velardi, E., Algeri, M., Merli, P., Galaverna, F., Locatelli, F.

Get full text

15 - Hematopoietic Stem/Progenitor Cells and Engineering: LONG-TERM DATA ON IMMUNE MONITORING OF CHILDREN GIVEN TCRαβ/CD19 CELL DEPLETED HLA-HAPLOIDENTICAL STEM TRANSPLANTATION (HAPLO-HSCT) by Bertaina, V., Sborgia, R., Marini, O., De Luca, C., Carta, R., Becilli, M., Pagliara, D., Quagliarella, F., Lucarelli, B., Boccieri, E., Velardi, E., Algeri, M., Merli, P., Galaverna, F., Locatelli, F.

Get full text

S691 Humoral Immune Response After Completion of COVID-19 Vaccine Series Among Patients With IBD by Weaver, Kimberly N, Kappelman, Michael, Boccieri, Margie E, Firestine, Ann M, Zhang, Xian, Long, Millie D

Get full text

Strong Response to SARS-CoV-2 Vaccine Additional Doses Among Patients With Inflammatory Bowel Diseases by Long, Millie D., Weaver, Kimberly N., Zhang, Xian, Chun, Kelly, Kappelman, Michael D., Watkins, R., Adler, J., Dubinsky, M.C., Kastl, A., Bousvaros, A., Strople, J.A., Cross, R.K., Higgins, P.D.R., Ungaro, R.C., Bewtra, M., Bellaguarda, E., Farraye, F.A., Boccieri, M.E., Firestine, A., Fernando, M., Bastidas, M., Zikry, M., Dai, X.

“…The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has disrupted health care and has resulted in high mortality rates.1 Vaccination is…”
Get full text

Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel Disease by Kastl, Arthur J., Weaver, Kimberly N., Zhang, Xian, Strople, Jennifer A., Adler, Jeremy, Dubinsky, Marla C., Bousvaros, Athos, Watkins, Runa, Dai, Xiangfeng, Chen, Wenli, Cross, Raymond K., Higgins, Peter D.R., Ungaro, Ryan C., Bewtra, Meenakshi, Bellaguarda, Emanuelle A., Farraye, Francis A., Chun, Kelly Y., Zikry, Michael, Fernando, Manory, Bastidas, Monique, Hernandez, Cristian G., Craig, Riley G., Boccieri, Margie E., Firestine, Anne, Long, Millie D., Kappelman, Michael D.

Get full text